Standards and perspectives in the diagnosis and treatment of pancreatic adenocarcinoma.
Despite certain advances, the overall prognosis for pancreatic carcinoma has remained extremely dismal. Even now, not more than 5% of all patients diagnosed as having pancreatic carcinoma survive 5 years. With this background, the standards and new developments for this entity are discussed.